greeksoup/ stocks
Stocks / United States / RVTY · Laboratory Analytical Instruments · NYSE

Revvity, Inc. (RVTY)

Compare with another name

Revvity, Inc. (RVTY) reported revenue of $730 million for Q2 FY2026, the quarter ended 5 July 2026, up 1.3% on the same quarter a year earlier. Net income was $52 million, down 3.9% on the year, and diluted earnings per share $0.47. The figures are the company's own, from the 10-Q it filed with the SEC on 11 August 2026.

Revenue$730 millionup 1.3%
Net income$52 milliondown 3.9%
Diluted EPS$0.47
QuarterQ2 FY2026ended 5 July 2026

Ratios

From the filings

ROE3.3%
ROCE3.4%
Operating margin12.3%
Net margin8.2%
FCF margin19.2%
Interest cover3.82
Debt to equity0.45
Cash conversion2.64
Share count, 1 year-4.1%
Sales CAGR, 3 yearsn/a
Profit CAGR, 3 yearsn/a
EPS, TTM$2.09

At the close of 21 September 2026

Price$143.59
Market cap$16.0 billion
Stock P/E68.70
Price to book2.22
EV / EBITDA23.63
Dividend yield0.2%
Market cap / sales5.50
52-week high$146.73
52-week low$82.26
Price, 1 year65.6%
Price CAGR, 3 years9.5%
Price CAGR, 5 years-4.9%

Every figure is arithmetic on the filed lines (hover a name for the formula); the priced ones use the latest daily close, CBOE delayed quotes, daily history, by CBOE, for splits. Debt to equity here stands on the total debt Revvity, Inc. states in its own filing, with lease liabilities counted separately and never inside it. Nothing here is a valuation or a view.

Price, 17 September 2021 to 21 September 2026

Daily closes from CBOE delayed quotes, daily history, by CBOE, for splits; the last is 21 September 2026. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Drawn in your browser; the range and overlay you pick are remembered here only.

The public record on RVTY

Filings18 in twelve months: 7 current reports (8-K), about 5 results of operations; 2 other events; 1 charter or bylaw amendment, or fiscal year change; 1 shareholder vote; 1 regulation fd disclosure
Planned insider sales9 Form 144 notices in twelve months, $6.0 million; latest 21 September 2026
Options tapeput/call 1.51 by open interest on 23 September 2026; the straddle prices a 7.7% move to 16 October 2026
Holders8 of the followed funds hold it; largest Geode Capital Management; 9 Schedule 13D or 13G filings in twelve months
Insider trading15 sales and 0 purchases on Form 4 in twelve months
Congress2 House trades disclosed in six months
Short interest6.3 million shares short, 4.13 days to cover at 31 August 2026
Documentsthe 10-K, the 10-Qs, the proxy and 5 earnings press releases, each linked

Quarterly results, the last 12 quarters

Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue671696650692684729665720699772711730
Cost of revenue298n/a295306299n/a289328324n/a323313
Gross profit373n/a355386385n/a376393375n/a388417
Gross margin56%n/a55%56%56%n/a56%55%54%n/a55%57%
R&D53.049.650.448.149.149.253.653.350.858.257.949.0
SG&A250257261252238244250249242252254279
Operating income69.277.244.185.798.211972.290.881.911275.989.3
Operating margin10%11%7%12%14%16%11%13%12%14%11%12%
Interest expense25.524.624.424.724.422.823.022.922.823.524.723.0
Pre-tax income50.631.434.586.710094.652.468.755.791.650.063.5
Tax rate36%-103%17%16%7%7%20%20%15%-5%18%16%
Net income9.578.626.055.494.494.642.253.946.798.440.751.8
Net margin1%11%4%8%14%13%6%7%7%13%6%7%
Diluted EPS$0.08$0.69$0.21$0.45$0.77$0.77$0.35$0.46$0.40$0.86$0.36$0.47
Operating cash flow-33.5197148159148174128134138182115192
Capital expenditure22.424.117.822.022.324.516.018.918.520.219.811.1
Free cash flow-55.817213013712615011211512016295.5181
Buybacks1114.910.819.615418515429420516886.516.0
Dividends paid8.78.68.68.68.68.58.48.38.18.07.87.8
Shares outstanding123m123m123m123m122m121m119m116m114m112m112m112m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Profit and loss, 10 fiscal years and the trailing twelve months

FY2008FY2012 FY2013 FY2014 FY2017 FY2018FY2019FY2023FY2024FY2025TTM
Revenue1,6602,1152,1582,2372,2572,7782,8842,7512,7552,8562,912
Cost of revenue9267637847087091,437n/an/an/an/an/a
Gross profit7349639771,0051,0731,3411,396n/an/an/an/a
Gross margin44.2%45.5%45.3%44.9%47.5%48.3%48.4%n/an/an/an/a
Research and development93.0132132108139194189217197216216
Selling, general and administrative4866275826486268128151,0239949921,026
Operating income148103228165296324362301347357359
Operating margin8.9%4.9%10.6%7.4%13.1%11.7%12.6%10.9%12.6%12.5%12.3%
Interest expensen/a45.849.936.343.967.063.698.896.392.294.0
Pre-tax income10455.2164124297258237183316268261
Income tax12.7-16.1-10.6-6.314020.29.43.533.128.423.4
Effective tax rate12.3%-29.2%-6.5%-5.1%47.1%7.8%4.0%1.9%10.5%10.6%9.0%
Net income12669.9167158293238228693270241238
Net margin7.6%3.3%7.7%7.1%13.0%8.6%7.9%25.2%9.8%8.4%8.2%
Diluted EPS$1.07$0.61$1.47$1.39$2.64$2.13$2.04$5.55$2.20$2.07$2.09
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

Income statement lines from each year's 10-K, the year linked to its filing; TTM is the sum of the last four quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Cash flow and capital returned

FY2008FY2012 FY2013 FY2014 FY2017 FY2018FY2019FY2023FY2024FY2025TTM
Operating cash flow21815215928228831136391.3628583628
Capital expenditure35.342.439.027.239.193.376.381.486.673.569.5
Free cash flow1831101202542492182879.9542509558
Free cash flow margin11.0%5.2%5.5%11.4%11.0%7.8%10.0%0.4%19.7%17.8%19.2%
Depreciation and amortisation77.4125127110105181214432428405412
Share-based compensation18.120.614.114.125.428.831.541.437.822.824.4
Buybacks75.52.112765.53.857.46.3389370821476
Dividends paid33.131.931.631.630.831.031.135.034.532.831.7
Dividend per sharen/a$0.28$0.28$0.28$0.28$0.28$0.28$0.28$0.28$0.28$0.28
Diluted shares, weightedn/a115m114m114m111m112m112m125m123m117m112m
Shares outstanding at period endn/a115m113m112m110m111m111m123m121m112m112m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

Buybacks and dividends are the cash paid in the year, from the cash flow statement; the dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet at year end

FY2008FY2012 FY2013 FY2014 FY2017 FY2018FY2019FY2023FY2024FY2025TTM
Total assetsn/a3,9023,9474,1346,0915,9766,53913,56512,39212,16812,046
Cash and equivalents1791731751752021631929131,1639201,023
Receivablesn/a457467471552633725633632745709
Inventoryn/a248261285352338357428368379379
Goodwilln/a2,1232,1432,2443,0022,9533,1116,5346,4646,6136,608
Total debt, as filedn/an/an/an/an/an/an/a3,9273,1723,2393,222
Long-term debtn/a9419351,0532,0061,8912,0743,9003,1502,6312,633
Borrowings, as the company tags themn/an/an/an/an/an/an/a12.33,1722,6502,650
Operating lease liabilitiesn/an/an/an/an/a0.0146133152148136
Shareholders' equity1,5681,9401,9942,0422,5032,5852,8147,8737,6677,2507,229
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

At the fiscal year end; the TTM column is the latest quarter end. A line the company does not tag under the usual name is left out.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compoundedn/an/an/a4.1%
Profit growth, compoundedn/an/an/a-16.7%
Return on equity, averagen/an/a5.2%3.3%

Compounded growth is the latest fiscal year over the year that many years earlier, annualised; the TTM column is the last four quarters over the four before. Return on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Peers: Laboratory Analytical Instruments

CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
Agilent Technologies, Inc. A$45.7 billion31.8819.6%22.2%8.6%0.490.6%
Waters Corp. WAT$41.6 billion105.721.1%7.1%52.5%0.32n/a
Illumina, Inc. ILMN$36.1 billion44.5629.1%19.7%4.9%0.53n/a
Mettler Toledo International Inc/ MTD$31.0 billion32.257,062.4%n/a6.9%164.70n/a
Revvity, Inc. RVTY$16.0 billion68.703.3%12.3%4.1%0.450.2%

The names on this site in the same industry (the SEC's SIC description), by market capitalisation. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close.

Filings

FilingPeriodFiledWhere
10-Q5 July 202611 August 2026EDGAR
10-Q5 April 202612 May 2026EDGAR
10-K28 December 202524 February 2026EDGAR
10-Q28 September 20254 November 2025EDGAR
10-Q29 June 20255 August 2025EDGAR
10-Q30 March 20256 May 2025EDGAR
10-K29 December 202425 February 2025EDGAR
10-Q29 September 20246 November 2024EDGAR
10-Q30 June 20246 August 2024EDGAR
10-Q31 March 20247 May 2024EDGAR

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install